Načítá se...
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
OBJECTIVE: We assessed CSF levels of the light chain subunit of neurofilaments (NfL) at baseline and after fingolimod therapy or placebo in patients with relapsing-remitting multiple sclerosis (RRMS). Changes in NfL levels were also correlated with relapse and MRI outcomes. METHODS: CSF samples were...
Uloženo v:
| Vydáno v: | Neurology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409586/ https://ncbi.nlm.nih.gov/pubmed/25809304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001491 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|